DXSP DXS International PLC

DXS International plc (AQSE:DXSP): ExpertCare featured in Innovate UK Research Project

DXS International plc (AQSE:DXSP): ExpertCare featured in Innovate UK Research Project

DXS INTERNATIONAL PLC (AQSE: DXSP)

ExpertCare featured in Innovate UK Research Project

DXS International plc ("DXS" or "the Company"), a leading provider of digital clinical decision support solutions, is thrilled to announce that its leading-edge digital health solution, ExpertCare, has been independently reviewed by the prestigious York Health Economics Consortium (YHEC) with results that confirm its powerful impact on both clinical outcomes and NHS cost-efficiency. 

Funded by DXS and Innovate UK and delivered in partnership with Health Innovation East, the evaluation assessed ExpertCare’s effectiveness in supporting medicines optimisation for patients with hypertension. The study, involving 2,484 patients across 13 UK GP practices, compared ExpertCare against standard hypertension review for GP practices. 

The evaluation found that ExpertCare delivers more effective hypertension control, reduces treatment variability, and is cost-saving in both the short and long term. 

The YHEC report concluded that: 

  • ExpertCare significantly increases the number of patients with optimally managed hypertension. 
  • For every £1 invested, ExpertCare returns £2.70 to the NHS. 

ExpertCare functions as an intelligent clinical decision support tool, streamlining data collection and generating treatment recommendations aligned with NICE guidelines—freeing up clinical time and improving outcomes at scale. 

David Immelman, CEO of DXS, commented: 

“We are incredibly proud of the results of this independent validation. It affirms our belief that ExpertCare has the potential to materially improve hypertension management across England, while reducing the cost burden on the NHS. These results highlight the real-world value of deploying ExpertCare nationally starting from year one.” 

For more information, please visit  

Contacts:

David Immelman



DXS International plc



-systems.com



 
01252 719800
AQSE Corporate Broker and Corporate Advisor



Hybridan LLP



Claire Louise Noyce
020 3764 2341

Notes to Editors

About DXS:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.

Attachment



EN
10/07/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DXS International PLC

Hybridan Team ... (+2)
  • Hybridan Team
  • Jon Levinson

Hybridan Research: DXS International plc: NHS Opportunity Remains

Despite bureaucratic headaches, the final results to 30 April report a 5% increase in revenue to £3.5m and a reduced loss to £94.8k. The P&L comparison with 2024 is awkward due to changes in accounting practises and the £4.7m impairment charge. The FY 2025 loss was affected by a sharp decline in allowable R&D which was down to £80k from £212k due to HMRC’s new restrictions on overseas development. DXS continues to significantly invest in innovation and developing solutions. These costs are now ...

 PRESS RELEASE

DXS International plc ((AQSE: DXSP) - Final Results

DXS International plc ((AQSE: DXSP) - Final Results DXS INTERNATIONAL PLC (AQSE: DXSP) ANNUAL RESULTS for the year ended 30 April 2025 The Board of DXS International plc (“the Company”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce its audited Final Results for the year ended 30 April 2025. Financial highlights: Revenue increased by 5% to £3,469,917 (2024: £3,308,359). Core recurring revenue model remains resilient.Available cash at the period end was £428,957 plus unutilised debtor drawdowns of £2...

 PRESS RELEASE

DXS International plc (AQSE:DXSP): ExpertCare featured in Innovate UK ...

DXS International plc (AQSE:DXSP): ExpertCare featured in Innovate UK Research Project DXS INTERNATIONAL PLC (AQSE: DXSP) ExpertCare featured in Innovate UK Research Project DXS International plc ("DXS" or "the Company"), a leading provider of digital clinical decision support solutions, is thrilled to announce that its leading-edge digital health solution, ExpertCare, has been independently reviewed by the prestigious York Health Economics Consortium (YHEC) with results that confirm its powerful impact on both clinical outcomes and NHS cost-efficiency.  Funded by DXS and Innovate UK and...

Hybridan Team ... (+2)
  • Hybridan Team
  • Jon Levinson

Hybridan Research: DXS International plc: Experts to Decide

DXS’s ExpertCare, a digital solution platform, is selected for the Grow Digital Health Midlands Programme. This Programme is a collaboration between Health Innovation East and West Midlands, to provide a platform to encourage digital innovation to address the NHS most pressing challenges. DXS will be exposed to the largest NHS England region, encompassing 11 Integrated Care Systems, and a population of approximately 11.8m people. The programme is designed to help UK technology innovators scale p...

 PRESS RELEASE

Company Update

Company Update DXS INTERNATIONAL PLC (AQSE: DXSP) ExpertCare selected for prestigious Grow Digital Health Midlands Programme DXS International plc ("DXS" or the "Company"), the digital clinical decision support company, is pleased to announce that ExpertCare, its digital medicine solution, has been selected for the prestigious Grow Digital Health Midlands Programme. Grow Digital Health Midlands - a new collaboration from Health Innovation East Midlands and Health Innovation West Midlands, has announced its first cohort of nine high-potential digital health companies of which DXS and the ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch